TT
Travere Therapeutics
Resolving
Resolving brand mentions across new media
Travere Therapeutics
Arcmira media summary
Arcmira tracks where Travere Therapeutics is discussed across indexed YouTube videos, transcripts, channels, and related entities.
Biotech company whose stock surged 37% following FDA approval for a kidney disease treatment.
Biotech firm whose stock slumped after an FDA request for clinical benefit clarification.
Biotech firm whose shares slumped after an FDA request for clinical benefit clarification.
3
Mentions
565
Views
“Biotech company whose stock surged 37% following FDA approval for a kidney disease treatment.”
“Biotech firm whose stock slumped after an FDA request for clinical benefit clarification.”
“Biotech firm whose shares slumped after an FDA request for clinical benefit clarification.”
Arcmira tracks 3 indexed media appearances or mentions for Travere Therapeutics, tied to source videos, channels, and transcript-derived context.
Arcmira uses indexed YouTube videos and transcripts. Representative source evidence on this page includes "Citi Gains, Adobe/Figma Slide, Travere Therapeutics Soars | Stock Movers" with transcript-derived context and links when available.
Travere Therapeutics is connected to Lisa Mateo, Carol Massar, Tim Stenovec in Arcmira's media graph.